D-sn-1-O-oleoyl-2-O-methylglyceryl-3-phosphothionate (2R-OMPT)

Catalog No.:  L-9318
MW: 452.63
CAS: 645408-60-2

Description:  OMPT is a metabolically-stabilized analog of Lysophosphatidic Acid (LPA) which acts as potent agonist for the LPA3 receptor. Of the two enantiomers, (2S)-OMPT is more potent than (2R)-OMPT showing 5-20 fold more activity in calcium release from LPA3-transfected Sf9 and rat hepatoma Rh7777 cells. (2S)-OMPT is also more potent in inducing calcium release, IL-6 production, and MAPK and Akt phosporylation in OVCAR3 cells.


-20 °C

Featured in Publications

1) Qian, L., Y. Xu, et al. (2003). "Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity." J Med Chem 46(26): 5575-8.
2) Altman, M. K., V. Gopal, et al. (2010). "Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid." Mol Cancer 9: 140.

Options/Sizes Pricing
L-9318-0.5mg $ 261.00
Additional Information:
Tech Data Sheet - L-9318

Add a specific quantity to your cart    *  

Back to the webstore startpage      Back to the product overview      Your Shopping Cart      Terms of Service

assay and reagents for drug discovery in lipid signaling pathways